The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory
Authors
Keywords
-
Journal
iScience
Volume 24, Issue 12, Pages 103479
Publisher
Elsevier BV
Online
2021-11-20
DOI
10.1016/j.isci.2021.103479
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nanomaterial Delivery Systems for mRNA Vaccines
- (2021) Michael D. Buschmann et al. Vaccines
- Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2
- (2021) Kimberly G. Blumenthal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of in vivo studies
- (2021) Cláudia Pina Costa et al. Acta Pharmaceutica Sinica B
- COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021
- (2021) Anat Achiron et al. Multiple Sclerosis Journal
- Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management
- (2021) Vivek P. Chavda et al. DRUG DISCOVERY TODAY
- Myocarditis and Pericarditis After Vaccination for COVID-19
- (2021) George A. Diaz et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Symptomatic Acute Myocarditis in 7 Adolescents After Pfizer-BioNTech COVID-19 Vaccination
- (2021) Mayme Marshall et al. PEDIATRICS
- Scent of a vaccine
- (2021) Frances E. Lund et al. SCIENCE
- Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models
- (2021) Neeltje van Doremalen et al. Science Translational Medicine
- Myocarditis following COVID-19 mRNA vaccination
- (2021) Saif Abu Mouch et al. VACCINE
- Peripheral and lung resident memory T cell responses against SARS-CoV-2
- (2021) Judith Grau-Expósito et al. Nature Communications
- Future considerations for the mRNA-lipid nanoparticle vaccine platform
- (2021) Botond Z Igyártó et al. Current Opinion in Virology
- Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military
- (2021) Jay Montgomery et al. JAMA Cardiology
- Myocarditis Occurring After Immunization With mRNA-Based COVID-19 Vaccines
- (2021) David K. Shay et al. JAMA Cardiology
- Brief communication: Long-term absence of Langerhans cells alters the gene expression profile of keratinocytes and dendritic epidermal T cells
- (2020) Qingtai Su et al. PLoS One
- Lipid Nanoparticles Potentiate CpG-Oligodeoxynucleotide-Based Vaccine for Influenza Virus
- (2020) Seiki Shirai et al. Frontiers in Immunology
- A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice
- (2020) Alec W. Freyn et al. MOLECULAR THERAPY
- Route of Vaccine Administration Alters Antigen Trafficking but Not Innate or Adaptive Immunity
- (2020) Sebastian Ols et al. Cell Reports
- Lipid nanoparticles for nucleic acid delivery: Current perspectives
- (2020) Eleni Samaridou et al. ADVANCED DRUG DELIVERY REVIEWS
- Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals
- (2020) Gergely Tibor Kozma et al. ADVANCED DRUG DELIVERY REVIEWS
- A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice
- (2020) Dorottya Laczkó et al. IMMUNITY
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Display of Native Antigen on cDC1 That Have Spatial Access to Both T and B Cells Underlies Efficient Humoral Vaccination
- (2020) Yu Kato et al. JOURNAL OF IMMUNOLOGY
- A vaccine combination of lipid nanoparticles and a cholera toxin adjuvant derivative greatly improves lung protection against influenza virus infection
- (2020) Valentina Bernasconi et al. Mucosal Immunology
- COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
- (2020) Ugur Sahin et al. NATURE
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
- (2020) Edward E. Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation
- (2020) Katlyn Lederer et al. IMMUNITY
- IgA dominates the early neutralizing antibody response to SARS-CoV-2
- (2020) Delphine Sterlin et al. Science Translational Medicine
- Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection
- (2020) Michael W. Russell et al. Frontiers in Immunology
- DC Subsets Regulate Humoral Immune Responses by Supporting the Differentiation of Distinct Tfh Cells
- (2019) Aurélie Bouteau et al. Frontiers in Immunology
- Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes
- (2019) Sita Awasthi et al. Science Immunology
- Linkage between endosomal escape of LNP-mRNA and loading into EVs for transport to other cells
- (2019) Marco Maugeri et al. Nature Communications
- Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses
- (2018) Norbert Pardi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility
- (2018) Jayesh A. Kulkarni et al. Nucleic Acid Therapeutics
- Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
- (2018) Norbert Pardi et al. Nature Communications
- Overview of the IL-1 family in innate inflammation and acquired immunity
- (2017) Charles A. Dinarello IMMUNOLOGICAL REVIEWS
- Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
- (2017) Norbert Pardi et al. NATURE
- Safety Evaluation of Lipid Nanoparticle–Formulated Modified mRNA in the Sprague-Dawley Rat and Cynomolgus Monkey
- (2017) Maja Sedic et al. VETERINARY PATHOLOGY
- A Protocol for the Comprehensive Flow Cytometric Analysis of Immune Cells in Normal and Inflamed Murine Non-Lymphoid Tissues
- (2016) Yen-Rei A. Yu et al. PLoS One
- A Tetravalent Sub-unit Dengue Vaccine Formulated with Ionizable Cationic Lipid Nanoparticle induces Significant Immune Responses in Rodents and Non-Human Primates
- (2016) Gokul Swaminathan et al. Scientific Reports
- Antibodies targeting Clec9A promote strong humoral immunity without adjuvant in mice and non-human primates
- (2015) Jessica Li et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Skin dendritic cells induce follicular helper T cells and protective humoral immune responses
- (2015) Chen Yao et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes
- (2015) Norbert Pardi et al. JOURNAL OF CONTROLLED RELEASE
- Complement activation-related pseudoallergy: A stress reaction in blood triggered by nanomedicines and biologicals
- (2014) Janos Szebeni MOLECULAR IMMUNOLOGY
- IL-6 in Inflammation, Immunity, and Disease
- (2014) T. Tanaka et al. Cold Spring Harbor Perspectives in Biology
- Cationic lipid nanocarriers activate Toll-like receptor 2 and NLRP3 inflammasome pathways
- (2013) Caroline Lonez et al. Nanomedicine-Nanotechnology Biology and Medicine
- Cationic lipids activate intracellular signaling pathways
- (2012) Caroline Lonez et al. ADVANCED DRUG DELIVERY REVIEWS
- Molecular signatures database (MSigDB) 3.0
- (2011) A. Liberzon et al. BIOINFORMATICS
- Trained Immunity: A Memory for Innate Host Defense
- (2011) Mihai G. Netea et al. Cell Host & Microbe
- Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA
- (2011) Katalin Karikó et al. NUCLEIC ACIDS RESEARCH
- Mechanistically Probing Lipid-siRNA Nanoparticle-associated Toxicities Identifies Jak Inhibitors Effective in Mitigating Multifaceted Toxic Responses
- (2010) Weikang Tao et al. MOLECULAR THERAPY
- DiC14-amidine cationic liposomes stimulate myeloid dendritic cells through Toll-like receptor 4
- (2008) Tetsuya Tanaka et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
- (2008) Katalin Karikó et al. MOLECULAR THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More